Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Offidani

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Pediatric Research|May 1, 1993
Changes of plasma lipids and erythrocyte membrane fluidity in psoriatic childrenG Ferretti, O Simonetti, A M Offidani, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 24, 2021
Treatment of primary axillary hyperhidrosis with a cream formulation of oxybutynin chloride 10G Kontochristopoulos, V Markantoni, E Agiasofitou, et al.
European Journal of Epidemiology|June 1, 1997
Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, ItalyD Arzeni, M Del Poeta, O Simonetti, et al.
Mycopathologia|April 20, 2001
Electrophoretic karyotyping and antifungal susceptibility patterns of Candida parapsilosis clinical isolates causing deep and superficial fungal infectionsF Barchiesi, L F Di Francesco, D Arzeni, et al.
The Journal of Investigative Dermatology|November 9, 2000
Carboxyfullerenes protect human keratinocytes from ultraviolet-B-induced apoptosisC Fumelli, A Marconi, S Salvioli, et al.
The British Journal of Dermatology|May 9, 2007
Differences in survivin location and Bcl-2 expression in CD30+ lymphoproliferative disorders of the skin compared with systemic anaplastic large cell lymphomas: an immunohistochemical studyG Goteri, O Simonetti, S Rupoli, et al.
The British Journal of Dermatology|April 7, 2018
MiR-146a-5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor-alpha inhibitor adalimumabE Mensà, R Recchioni, F Marcheselli, et al.
The Journal of Dermatological Treatment|January 16, 2018
Secukinumab in multi-failure psoriatic patients: the last hope?M Magnano, C Loi, A Patrizi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 3, 2020
Creation of a severity index for hidradenitis suppurativa that includes a validated quality-of-life measure: the HIDRAscoreA V Marzano, A Chiricozzi, G Giovanardi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 11, 2020
Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experienceM C Fargnoli, M Esposito, P Dapavo, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Pediatric Research|May 1, 1993
Changes of plasma lipids and erythrocyte membrane fluidity in psoriatic childrenG Ferretti, O Simonetti, A M Offidani, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 24, 2021
Treatment of primary axillary hyperhidrosis with a cream formulation of oxybutynin chloride 10G Kontochristopoulos, V Markantoni, E Agiasofitou, et al.
European Journal of Epidemiology|June 1, 1997
Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, ItalyD Arzeni, M Del Poeta, O Simonetti, et al.
Mycopathologia|April 20, 2001
Electrophoretic karyotyping and antifungal susceptibility patterns of Candida parapsilosis clinical isolates causing deep and superficial fungal infectionsF Barchiesi, L F Di Francesco, D Arzeni, et al.
The Journal of Investigative Dermatology|November 9, 2000
Carboxyfullerenes protect human keratinocytes from ultraviolet-B-induced apoptosisC Fumelli, A Marconi, S Salvioli, et al.
The British Journal of Dermatology|May 9, 2007
Differences in survivin location and Bcl-2 expression in CD30+ lymphoproliferative disorders of the skin compared with systemic anaplastic large cell lymphomas: an immunohistochemical studyG Goteri, O Simonetti, S Rupoli, et al.
The British Journal of Dermatology|April 7, 2018
MiR-146a-5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor-alpha inhibitor adalimumabE Mensà, R Recchioni, F Marcheselli, et al.
The Journal of Dermatological Treatment|January 16, 2018
Secukinumab in multi-failure psoriatic patients: the last hope?M Magnano, C Loi, A Patrizi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 3, 2020
Creation of a severity index for hidradenitis suppurativa that includes a validated quality-of-life measure: the HIDRAscoreA V Marzano, A Chiricozzi, G Giovanardi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 11, 2020
Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experienceM C Fargnoli, M Esposito, P Dapavo, et al.
Pageof 4